Zoledronic and Kanjinti drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Zoledronic (zoledronic acid) and Kanjinti (trastuzumab-anns). Common drug interactions include left ventricular dysfunction among females.
The phase IV clinical study analyzes what interactions people have when they take Zoledronic and Kanjinti. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Zoledronic?
Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.
What is Kanjinti?
Kanjinti has active ingredients of trastuzumab-anns. eHealthMe is studying from 1,241 Kanjinti users. Check the latest studies of Kanjinti.
13 people who take Zoledronic and Kanjinti together, and have interactions are studied.
What are the common drug interactions of Zoledronic and Kanjinti, by gender? *:
female:
- Left ventricular dysfunction
- Abdominal pain upper
- Vulvovaginal dryness
- Chest discomfort
- Alopecia (absence of hair from areas of the body)
- Anxiety
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Neuropathy peripheral (surface nerve damage)
- Palpitations (feelings or sensations that your heart is pounding or racing)
male:
n/a
What are the common drug interactions of Zoledronic and Kanjinti, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Back pain
- Chest pain
- Dizziness
- Dry skin
- Dysgeusia (disorder of the sense of taste)
- Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
- Vulvovaginal dryness
- Chest discomfort
- Left ventricular dysfunction
- Abdominal pain upper
60+:
- Alopecia (absence of hair from areas of the body)
- Anxiety
- Fatigue (feeling of tiredness)
- Nausea (feeling of having an urge to vomit)
- Neuropathy peripheral (surface nerve damage)
- Vomiting
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 11 people, 84.62%
- Breast Cancer: 11 people, 84.62%
- Dry Skin: 2 people, 15.38%
- Back Pain: 2 people, 15.38%
- Anaemia (lack of blood): 2 people, 15.38%
* Approximation only. Some reports may have incomplete information.
Do you take Zoledronic and Kanjinti?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Zoledronic (29,812 reports)
- Kanjinti (1,241 reports)
Browse all drug interactions of Zoledronic and Kanjinti:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zoledronic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Kanjinti:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zoledronic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Kanjinti and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid and trastuzumab-anns (the active ingredients of Zoledronic and Kanjinti, respectively), and Zoledronic and Kanjinti (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tretinoin cause Thrombocytopenia? - a second ago
- Could Cialis cause Broken Bone? - 3 seconds ago
- Could Methylprednisolone cause Varicose Vein? - 3 seconds ago
- Could Botox cause Escherichia Urinary Tract Infection? - 6 seconds ago
- Could Botox cause Bedridden? - 9 seconds ago
- Drug interactions of Estropipate and Nuvigil - 18 seconds ago
- Could Formoterol Fumarate cause Nausea And Vomiting? - 20 seconds ago
- Tazorac vs. Keflex, side effect and effectiveness comparison - 28 seconds ago
- Drug interactions of Medrol and Ampyra - 30 seconds ago
- Could Sulfamethoxazole cause Joint Swelling? - 31 seconds ago